Page last updated: 2024-08-17

bromodeoxyuridine and Lymphoma, B-Cell

bromodeoxyuridine has been researched along with Lymphoma, B-Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, E; Dubé, ID; Hough, MR; Jolicoeur, P; Lim, MS; Liu, J; Rosic-Kablar, S	1
Agur, Z; Schechter, B; Tagliabue, G; Ubezio, P	1

Other Studies

2 other study(ies) available for bromodeoxyuridine and Lymphoma, B-Cell

Article	Year
Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice. Oncogene, 2006, Apr-27, Volume: 25, Issue:18 Topics: Animals; B-Lymphocytes; Bromodeoxyuridine; Cdc20 Proteins; Cell Cycle Proteins; Cyclin A; Cyclin B; Cyclin B1; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Genes, cdc; Homeodomain Proteins; Humans; Immunoglobulin Heavy Chains; Lymphoma, B-Cell; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Insertional; Proviruses; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spindle Apparatus	2006
Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics. Cancer research, 1994, Dec-15, Volume: 54, Issue:24 Topics: Animals; Bone Marrow; Bromodeoxyuridine; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Drug Synergism; Female; G1 Phase; G2 Phase; Lymphoma, B-Cell; Mice; Mice, Inbred C3H; Mitosis; S Phase; Time Factors	1994

Article

Year

Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice.

Oncogene, 2006, Apr-27, Volume: 25, Issue:18

Topics: Animals; B-Lymphocytes; Bromodeoxyuridine; Cdc20 Proteins; Cell Cycle Proteins; Cyclin A; Cyclin B; Cyclin B1; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Genes, cdc; Homeodomain Proteins; Humans; Immunoglobulin Heavy Chains; Lymphoma, B-Cell; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Insertional; Proviruses; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spindle Apparatus

2006

Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics.

Cancer research, 1994, Dec-15, Volume: 54, Issue:24

Topics: Animals; Bone Marrow; Bromodeoxyuridine; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Drug Synergism; Female; G1 Phase; G2 Phase; Lymphoma, B-Cell; Mice; Mice, Inbred C3H; Mitosis; S Phase; Time Factors

1994